...
首页> 外文期刊>Archives of gynecology and obstetrics. >Prospective comparison of indwelling cannulas drain and needle aspiration for symptomatic seroma after mastectomy in breast cancer patients
【24h】

Prospective comparison of indwelling cannulas drain and needle aspiration for symptomatic seroma after mastectomy in breast cancer patients

机译:乳腺癌患者乳房切除术后患有肠道血清瘤的前瞻性比较和针刺血肿

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Postoperative seroma is the most frequent sequelae after mastectomy and axillary surgery with no optimal regimens for seroma resolution recommended in routine clinical. Indwelling cannulas with needle and catheter have been widely used in long-term medication therapies, but evidence of indwelling cannulas in seroma management after mastectomy is lacking. The purpose of this study is to evaluate the feasibility of indwelling cannulas in seroma management after mastectomy. Methods Patients who underwent modified radical mastectomy (MRM) and developed symptomatic seroma after removal of the drains between August 2017 and December 2018, were randomized into two groups either indwelling cannulas drain of seroma (Group A) or needle aspiration of seroma (Group B). We prospectively compared the number of visits for seroma, the time from removal of the drain to the final seroma resolution and the cost between the methods. Results A total of 860 patients underwent MRM between August 2017 and December 2018, among which 86 patients who developed symptomatic seroma after removal of the drains, were randomized into two groups either Group A or Group B. The number of visits for seroma in Group A was 2.35 +/- 0.69 times, which was less than those in Group B (4.86 +/- 1.06 times). Similarly, the time of drain removal to final seroma resolution in Group A was 4.65 +/- 0.78 days, which was shorter than 7.09 +/- 1.54 in Group B. In Group A, the total mean cost per patient (25.81 +/- 7.71 RMB) was less than the total mean cost per patient (49.30 +/- 9.85 RMB) in Group B. Cost savings were noted with using indwelling cannulas in seroma management. Conclusion It is feasible to drain indwelling cannulas drain for postmastectomy seroma, with less visits for patients, rapid seroma resolution and less cost. Indwelling cannulas can be an efficient, cost effective solution to treat symptomatic seroma after breast surgery.
机译:术后血清瘤是乳房切除术后最常见的后遗症和腋窝手术,没有用于常规临床的血清瘤分辨率的最佳方案。用针和导尿管留住套管已广泛用于长期用药疗法,但缺乏乳房切除术后患有血清瘤管理中的套管的证据。本研究的目的是评估乳房切除术后培养的血清瘤管理中的留住通道的可行性。方法在2017年8月至2018年8月间移除漏斗后,接受改性自由基乳房切除术(MRM)和发育症状血型症的患者随机分为两组血清瘤(A组)或针血管针的肠道漏流(B组) 。我们预期比较了血清瘤的访问次数,从排水到最终血清瘤分辨率的时间和方法之间的成本。结果总共860名患者于2017年8月至2018年12月之间接受过MRM,其中86名在移除漏斗后发育症状血清瘤的患者,随机分为两组A或Group B. A组中血清瘤的访问次数是2.35 +/- 0.69倍,比B组(4.86 +/- 1.06次)小。类似地,排放到A组中最终血清瘤分辨率的时间为4.65 +/- 0.78天,B组中短于7.09 +/- 1.54.在A组,每位患者的总平均成本(25.81 +/- 7.71人民币)小于B组每位患者的平均成本(49.30 +/- 9.85元)。在血清瘤管理中使用留置通风,用餐节省成本。结论排出后切除肺部血清瘤的套管排水管是可行的,对患者的差异较少,血清瘤解决方案快速,成本较低。留住套餐的套管可以是乳房手术后治疗症状血清瘤的有效,具有成本效益的解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号